PETALING JAYA — In a milestone development for Malaysian healthcare innovation, RENN Asia Wellness has partnered with China’s Jian Shi Tang (JST) to establish a new Nutritional and Functional Medicine (NFM)-based diabetes treatment centre in Guangzhou, marking a major expansion of Malaysian clinical expertise into the Chinese healthcare system.
Situated in Leatop Plaza, Tianhe, the centre is built upon the comprehensive NFM clinical model developed in Malaysia, representing a new direction for diabetes management in China. Instead of concentrating merely on symptom suppression, NFM emphasises root-cause intervention, lifestyle correction, nutritional optimisation and continuous clinical monitoring.
RENN Asia CEO Jonathan Chew explained that the initiative complements China’s evolving healthcare reforms, which are now more focused on prevention, sustainability and personalised health strategies. However, he highlighted that existing systems still lack strong integration between lifestyle intervention, nutrition-based medicine and structured functional diagnostics.
The Malaysian-developed NFM framework, he said, bridges that gap by providing structured individual assessments, targeted nutritional therapy, metabolic stabilisation strategies and long-term health management planning.
Senior Malaysian NFM expert Prof Datuk Seri Steve Yap said the project is a testament to Malaysia’s capability to export world-class medical methodologies. He emphasised that the success of Malaysia’s clinical experience is now being acknowledged beyond national borders, proving the global relevance of Malaysian-developed healthcare models.
He also revealed that Malaysia will continue supporting JST during the centre’s early operational phase by providing advisory expertise, programme design guidance and clinical consultation to ensure seamless implementation.
JST Chief Medical Practitioner Dr Dai Qi Ming said the collaboration marks a turning point in Guangzhou’s approach to chronic disease care. The partnership, he added, reflects confidence in Malaysia’s NFM expertise and aligns perfectly with China’s goal of enhancing disease prevention while improving public health.
Beginning with diabetes, the initiative aims to reduce complications, improve patient outcomes and elevate the overall standard of chronic disease management in Guangzhou. If successful, both parties intend to expand cooperation to cover additional chronic illnesses.
Beyond healthcare outcomes, the collaboration carries strategic meaning. It positions Malaysia as a credible contributor to regional medical innovation, demonstrates the strength of Malaysia-China professional collaboration, and highlights the global potential of Malaysian clinical frameworks.
Ultimately, the new centre represents more than just a healthcare facility — it signifies Malaysia’s growing role in shaping future-oriented healthcare solutions in Asia, reinforcing the country’s standing as a serious player in NFM and chronic disease management expertise.
